0001209191-17-043399.txt : 20170705 0001209191-17-043399.hdr.sgml : 20170705 20170705180447 ACCESSION NUMBER: 0001209191-17-043399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cagle Gerald D. CENTRAL INDEX KEY: 0001589991 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 17949617 MAIL ADDRESS: STREET 1: 135 U.S. HIGHWAY 206 STREET 2: SUITE 15 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-30 0 0001539029 Clearside Biomedical, Inc. CLSD 0001589991 Cagle Gerald D. C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Stock Option (right to buy) 9.11 2017-06-30 4 A 0 2632 0.00 A 2027-06-29 Common Stock 2632 2632 D The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 30, 2018. /s/ Brian F. Leaf, Attorney-in-Fact 2017-07-05